The proto-oncogene c-fos has been implicated in the modulation of various cell functions. We have found that thrombin, a pleiotropic activator of endothelial cells, induced c-fos mRNA in human umbilical vein endothelial cells (HEC). This effect was dose-related (0.05 to 1 .O U/mL) and transient (maximal after 1 hour and negligible within 4 hours). Since thrombin activates phosphoinositide (PI1 turnover through a pertussis toxin (PTI-sensitive guanosine triphosphate-binding regulatory protein(s) (G-protein) with subsequent stimulation of protein kinase C (PKC) and Ca2+ movements, we investigated whether these intracellular pathways are also responsible for c-fos induction. PT inhibited thrombin's effect on c-fos expression, but had no effect on c-fos expression by phorbol myristate acetate XPRESSION of c-fos was initially studied in relation to 
stimulation of c-fos mRNA level were not inhibited by quin2: on the contrary, ionomycin effect was blocked by this agent. These results indicate that thrombin-induced c-fos expression in HEC does not require a fully active PKC but is dependent on normal intracellular Ca2+ availability. 0 1990 by The American Society of Hematology.
Petri dishes (Falcon, Cockeysville, MD). Monolayers were washed twice with serum-free medium 199 and maintained for 20 hours in medium 199 with 20% NCS, but without ECGS and heparin. Before stimulation cells were washed twice with serum-free medium 199. Stimulation was in serum-free medium 199 with 20 mmol/L Hepes (N-2-hydroxyethylpiperazine-N-2 ethanesulfonic acid). The stimuli used were: purified human-a thrombin (specific activity 1,665 U/mL), a gift from Dr J. Fenton (Albany, NY); ionomycin (Calbiochem, San Diego, CA); phorbol myristate acetate (PMA, Sigma); human recombinant interleukin-1S (IL-IS; specific activity lo3 U/pg protein), a gift from Dr A. Tagliabue (Sclavo Laboratories, Siena, Italy); human recombinant basic fibroblast growth factor (bFGF), a gift from Dr F. Bertolero (Carlo Erba, Milan, Italy); and hirudin, a gift from Dr K. Stocker (Pentapharm, Basel, Switzerland). When cycloheximide (CH) (20 pg/mL, Sigma) was used it was added to cells just before stimulation when incubation was up to 1 hour. For longer incubations CH was added 1 hour before the end of the experiment.
For PT (a kind gift from Dr R. Rappuoli, Sclavo Laboratories) treatment, cells were incubated with F' T (100 ng/mL) for 3 hours before stimulation in serum-free medium 199 with 20 mmol/L Hepes. This treatment was selected on the basis of preliminary experiments in which it inhibited PI stimulation by thrombin of 50% to 70% (PI stimulation was measured as described in ref 15) (range of three experiments, M.G.L. unpublished observations).
For long-term treatment with PMA, PMA (200 ng/mL) was added in medium 199 with 20% NCS. Seventy-two hours later cells were washed with serum-free medium 199 and stimulated as described. For quin2 (quin2 acetoxymethylester, Sigma) treatment, Total cellular RNA was isolated by guanidine isothiocyanate method.'3 At the end of the incubation time, cells were washed three times with isotonic saline and lysed with 2.5 mL ice-cold guanidine isothiocyanate. Three dishes per treatment were pooled. Fifteen micrograms of total RNA, unless otherwise stated, were analyzed by electrophoresis, through 1% agarose formaldehyde gels. To evaluate the quality and quantity of nucleic acids loaded in each lane, RNA samples were added with ethidium bromide (final concentration: 15 pg/mL) and, after electrophoresis, the gel was observed by an ultraviolet (UV) source.
Thereafter, RNA was blotted to Gene Screen Plus membranes (New England Nuclear, Boston. MA). The plasmids p f 0 s -3 '~ and a-actin" were labeled to high specific activity with a-/32P/dCTP (3,000 Ci/mmol; Radiochemical Center, Buckingamshire, UK) by nick translation." Membranes were pretreated and hybridized in 50% formamide (Merck and Co. Rahway, NJ) with 10% dextran sulfate (Sigma) and washed two times with 2 x SSC (1 x SSC 0.1 5 mol/L sodium chloride, 0.01 5 mol/L sodium citrate) and 1% sodium dodecyl sulfate (SDS) (Merck) at 60°C for 30 minutes, and finally two times with 0.1 x SSC at room temperature for 30 minutes. The membranes were autoradiographed onto x-ray films (X-OMAT AR, Kodak, Rochester. NY) for 12 to 48 hours at -SOT using intensifying screens. The proto-oncogene e-fos probe was removed from membranes according to manufacturer's instructions and membranes were hybridized to a-actin probe under the same experimental conditions.
The optical density of the autoradiographic bands integrated for the band area was evaluated by a digitalized image analyzer (RAS 3000, h a t s System, Amersham, Buckingham, UK). The "relative induction" was determined as described by McCaffrey et aIz4 by dividing the densitometric quantitation of the induced bands by the densitometric quantitation of the unstimulated band. When c-fos mRNA level in unstimulated cells was undetectable even in the presence of CH (17 of 27 experiments), its value was arbitrarily set at 1,000 for calculation. When measurable, control values ranged from 750 to 1,300 arbitrary units (range of 10 experiments).
Analysis of mRNA levels.
Quuntitution of autoradiogruphy.
LAMPUGNANI ET AL

RESULTS
As shown in Fig 1 exposure of HEC to thrombin for 1 hour resulted in induction of c-fos proto-oncogene expression. This effect was similar to that induced by a Ca" ionophore, ionomycin, and by a PKC activator, PMA.
The amount and quality of RNA loaded on agarose gels was checked by ethidium bromide staining. Moreover, after blotting, membranes were examined by short wavelength UV the experiments, membranes were rehybridized with a-actin probe after hybridization of the membranes with a c-fos probe. For typical result see Fig 7. Similarly to PMA and ionomycin, thrombin-induced c-fos expression was markedly superinduced by CH, as shown in Fig 1. However, c-fos expression after thrombin was observed also in the absence of CH. In 10 of 27 experiments CH caused a slight c-fos expression on its own. c-fos mRNA level after thrombin in the presence of CH was three to sixfold the level detectable in the absence of CH. As in the absence of CH, c-fos mRNA band in response to thrombin was fainter, this could make difficult the interpretation of inhibitory effects. CH was included in all the following reported experiments.
As reported in Fig In an effort to identify thrombin as actually responsible for the observed effect on c-fos expression in HEC we used hirudin. Hirudin forms a high-affinity noncovalent complex with thrombin (ref 21 and references therein) inhibiting its enzymatic activity. Hirudin (5 U/mL) preincubated with thrombin (1 U/mL) before addition to HEC prevented c-fos expression (Fig 3) . Moreover, hirudin can reverse the interaction of thrombin with its cellular receptor.25. 26 We therefore used this capacity to test whether brief contacts of thrombin with HEC were effective to induce c-fos mRNA transcript.
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When hirudin was added to HEC I minute after thrombin c-jo,~ expression was still present (Fig 3) (75% to 83T of the level obcrved after thrombin alone. range of three experiments).
Thrombin. following interaction with its own receptor and through a PT-sensitive G-protein regulatory mechanism (see Materials and Methods). activates PI turnover with subsequent activation of PKC and increase in Ca,-".".'" In addition. PKC activation by PVA and increase in Ca," by ionomycin were able to induce c-Jo.r expmsion in HEC as rcported in Fig I. We therefore investigated the role of these intracellular efTector systems in thrombin-induced c-@ expression in HEC.
We demonstrate in Fig 4 that PT (at a concentration and time of incubation able to block PI turnover. see Materials and Methods). inhibited c-jo.r induction by thrombin. c-105 Transcript levels after PT were in the range of 33% to 5oOr of the densitometric quantitated values of thrombin alone in three separate experiments. In contrast. as expected. the effect of PMA. which directly activated PKC. was not affected by PT. thus indicating that PT effect was not related to an unspecific inhibition of the cell ability to express c-fo.r (Fig 4) . Thesedata indicate that c-jo.~ induction by thrombin depends on a PT-sensitive G-protein coupling mechanism.
We then tested the role of PKC in c-jo.r induction by thrombin. To this aim we used PKC-deficient HEC: the cells were treated with PMA (200 ng/mL) for 72 hours to down regulate PKC activity." In 72-hour PMA-treated cells c=/o..c expression was barely detectable (7.9-fold lower than in control cells treated with PMA for I hour, Fig 5 ) . The response of 72-hour PMA-treated cells to a second stimulation with PMA (200 ng/mL) was impaired. indicating that PKC was indeed inhibited (the response ranging from ?W to 4 7 7 of that observed after PMA in control cells. values obtained in three separate experiments). When the 72-hollr PHA-treated cells were activated with thrombin and ionomycin they were fully responsive showing that an intact PKC is not required for c-fo.~ induction by these stimuli (Fig 5 ) .
We then tested the role of Ca," increase, in thc stimulation of c-/osexprcssion by thrombin. Thrombin induces Ca" mobili7srion both from the extracellular environment and from the intracellular stores.'"" To evaluate first the role of external Ca". thrombin was added to HEC in a Ca"-free medium. I n this condition the effect of thrombin. similar to that of ionomycin. was only partly reduced (Fig 6) (the level of c-/o.s m R N h ranging in three experiments from 64% to 82% and from 47% to 75% of the values obtained in response to thrombin and ionomycin. respectively. in the presence of extracellular Ca?'). In contrast. the response to PMA was essentially unafTected (Fig 6) . These data indicate that c-/os induction by thrombin is only moderately dependent on Ca" mobili7;ltion from the extracellular environment.
To also block the increase of Ca; ' from intracellular LAMPUGNANI ET AL storages the cells were loaded with quin2 in the absence of external Ca". We have previously shown that this procedure is effective in abolishing Ca," increase after thrombin." In this condition the response to thrombin and ionomycin was suppressed (Fig 6) or very strongly inhibited (Fig 7) .
indicating that thrombin induction of c-/o.r requires a Ca,? ' increase.
The effect of quin2 did not appear to be due to a general inhibition of transcription since. as reported in Fig 7. actin is regularly exprcsed. In addition. quin2 effect is specific for thrombin and ionomycin since other stimuli. which we have previously shown" '' to induce c-jo.r expression as bFGF and IL-18. were not atTected (Fig 7) .
During this study. performed during a period of more than CaZ+ movements by thrombin." Even if each cell preparation was obtained starting from a pool of at least three umbilical funnels, individual variability of the donors could explain the change in cell response as previously discussed for other HEC with qualitatively comparable results.
DISCUSSION
We have shown here that thrombin can induce c-fos proto-oncogene mRNA expression in HEC in a range of concentrations comparable with that inducing the majority of the other functional responses in these cell^^-'^ and likely to be reached locally in vivo (ref 21 and references therein). As described in other cell types for various stimuli c-fos expression was transient, peaking about 1 hour after the stimulus and disappearing within 4 hours. In HEC the kinetics of functional responses to thrombin vary from very rapid effects with peaks in a few minutes (for eg, PGI2 production: platelet activating factor [PAF] release6 and von Willebrand factor [vWF] release') to slow effects that peak from 30 minutes to some hours after thrombin addition (for eg, plasminogen activator' and plasminogen activator inhibitor release: IL-1 release," c-sis mRNA transcription" and platelet-derived growth factor (PDGF) synthesis," extracellular matrix organi~ation,'~ and mitogenesisi4). If c-fos plays a role in the development of such functional responses to thrombin its time course suggests that it might be involved in the regulation of the slow-developing responses. We report here that thrombin-induced c-fos expression is superinduced by CH. CH superinduced c-fos expression in HEC also in response to PMA and ionomycin (Fig 1) . We reported a similar effect of CH in HEC after stimulation with IL-lB, aFGF, bFGF, and serum. one of these negative regulatory proteins being the c-fos protein itself."."
Hirudin is able to specifically inhibit thrombin activity by binding to it and blocking or reversing its interaction with the receptor.:'.?" As reported here. hirudin given to HEC I minute after thrombin did not suppress c-fo.T expression. but it was effective when given together with thrombin. This suggests that the chain of intracellular signals resulting in c+s activation should develop within 1 minute of thrombin stimulation of HEC. This may be relevant to the in vivo situation in which active thrombin probably stimulates the endothelium just for brief periods being rapidly inactivated by plasmatic and cellular inhibitors.". '" I n this study we attempted to define the mechanism of action of thrombin in inducing c-jio.~. Of the various second messenger pathways that have been implicated in c-fo.~ expression. activation of PKC and/or an increase in Ca," seemed good candidates as mediators of thrombin activation of c-fos in HEC. Thrombin induces PI turnover"." by a PT-sensitive mechanism with a consequent activation of PKC and increase in Ca," within secondsof interaction with HEC. PI turnover induced by thrombin can be strongly reduced by PT (see Materials and Methods) . We found that PT could also significantly inhibit c-fos expression. This suggests that both activities are regulated by a rmptor controlled by a PT-sensitive G-protein.".'n To investigate the role of PKC activation in c-fos expression. the enzyme can be down regulated by long-term pretreatment with PMA.?. HEC pretreated with PMA for 72 hours expressed a very low level of c-fo.~ mRNA and their response to a second stimulation with PMA was inhibited. However, thrombin was as active in these cells as in control cells. indicating that its effect on c-fo.~ can p r d normally, independently of a fully active PKC. Similarly, ionomycin's effect on c-fos was not inhibited but was even slightly stimulated in HEC pretreated with PMA for 72 hours.
The possibility that the thrombin effect might be mediated by a Ca," increase was then tested. Ca:' level and increase can be quenched by loading cells with the Ca" chelator quin2 in the absence of extracellular Ca".' O This method has been used to verify the functional consequences of chelating Ca," in cells exposed to various We found that thrombin's effect was strongly inhibited in quin2-loaded cells. As expected, when the Ca*'-ionophore ionomycin was used as a stimulus. c-fo.~ expression was suppressed. This suggests that intracellular Ca" availability is important in c-f.s expression by thrombin. Low or no extracellular Ca-'-only slightly inhibited the effect of thrombin and ionomycin. Thrombin mobilizes Ca" both from the extracellular medium and from intracellular stores."." as the Ca," increase is only partially inhibited by EGTA in the extracellular medium.".'" The same explanation applies to ionomycin. In some experiments the PMA effect was also partly dependent on Ca 1%. as it was partially inhibited in quin2-loaded cells.
However. the effect of PMA was not inhibited by low extracellular Ca" . In the living cell PKC activation by PMA does not require an increase in Ca," as PMA enhances PKC affinity for Ca". so that PKC can be active at basal Ca," levels." However. quin2 loading in the absence of extracellular Ca" can decrease Ca,:' to below the basal This might explain why in some experiments the effect of PMA could be partially inhibited in quin2-loaded cells (Fig 6) .
In conclusion. the data reported here indicate that an intact PKC activity is unnecessary to c-fo.9 induction by thrombin in HEC. However. increases in Ca,:' appear to be an essential step to c-jo.~ expression in HEC after thrombin. Interestingly. another thrombin-mediated function. PG I2 release. has been shown to be independent of PKC but dependent on intracellular Ca" increase." The Ca,: ' dependency of thrombin response is not a common feature of c-fo5 induction in HEC since. as reported here. other stimuli such as IL-l and bFGF were able to induce expression of this oncogene in the presence of quin2 and in the absence of external Ca?'.
For
org From
The role of c-fos in the functional activation of HEC by thrombin remains to be defined. We have found that other nonmitogenic (IL1, TNF)44-46 and mitogenic (aFGF, bFGF)'9.47 stimuli can induce c-fos mRNA in HEC. These stimuli have very different effects on HEC in terms of mechanism of action, type of responses, or kinetics of effects. If c-fos expression is important in the effects of all these agonists on HEC the specifity of response to the different stimuli might be achieved through the simultaneous activation or repression of other genes, perhaps through c-fos itself. Indeed c-fos gene product has been recently shown to act as a transactivator of transcription, not binding directly to DNA, but interacting with other sequence-specific transcriptional activators such as c J u~/ A P~.~,~* ,~~ c-fos protein has also been shown to be both a negative'.'' and a po~itive''.~~ transregulator of transcription, so it could be a general modulator with pleiotropic activities, its activity perhaps depending on its state of pho~phorylation.'~
